Beta-carotene link to "significantly" increased fatal heart disease reviewed -- Lancet.
This article was originally published in The Tan Sheet
Executive Summary
BETA-CAROTENE LINK TO "SIGNIFICANTLY" INCREASED FATAL HEART DISEASE is reviewed in a study by Janne Rapola, MD, National Public Health Institute, Helsinki, Finland, et al., published in the June 14 issue of The Lancet. The study involved 1,862 men enrolled in the Alpha-tocopherol and Beta-carotene Cancer Prevention Study who had a previous myocardial infarction. The subjects received dietary supplements of alpha-tocopherol (50 mg/day), beta-carotene (20 mg/day), both or placebo.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning